JBIO Stock Overview

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. More details

JBIO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Jade Biosciences, Inc. Competitors

Entrada Therapeutics

NasdaqGM:TRDA

US$332.1m

Abeona Therapeutics

NasdaqCM:ABEO

US$318.4m

Rigel Pharmaceuticals

NasdaqGS:RIGL

US$345.9m

Aura Biosciences

NasdaqGM:AURA

US$308.9m

Price History & Performance

Summary of share price highs, lows and changes for Jade Biosciences
Historical stock prices
Current Share Price	US$12.48
52 Week High	US$13.50
52 Week Low	US$9.02
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	23.08%

Recent updates

Shareholder Returns

	JBIO	US Biotechs	US Market
7D	n/a	1.9%	2.8%
1Y	n/a	-6.9%	9.3%

Return vs Industry: Insufficient data to determine how JBIO performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how JBIO performed against the US Market.

Price Volatility

Is JBIO's price volatile compared to industry and market?
JBIO volatility
JBIO Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.8%
Market Average Movement	7.9%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	4.2%

Stable Share Price: JBIO's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine JBIO's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2024	n/a	Tom Frohlich	jadebiosciences.com

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.

Jade Biosciences, Inc. Fundamentals Summary

How do Jade Biosciences's earnings and revenue compare to its market cap?
JBIO fundamental statistics
Market cap	US$402.30m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is JBIO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JBIO income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did JBIO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/04 05:47
End of Day Share Price	2025/05/02 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jade Biosciences, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tyler Van Buren	TD Cowen

Jade Biosciences NasdaqCM:JBIO Stock Report